Vericel Reports Second Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance
August 04, 2021 08:00 ET
|
Vericel Corporation
Second Quarter Total Net Revenue Increased 97% to $39.5 Million Full-Year 2021 Revenue Guidance Raised to $168-$171 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Aug. 04,...
Vericel to Report Second-Quarter 2021 Financial Results on August 4, 2021
July 21, 2021 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., July 21, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel to Present at the Ladenburg Thalmann Healthcare Conference on Tuesday, July 13, 2021
July 07, 2021 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., July 07, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...
Vericel Provides Regulatory Update for NexoBrid
June 29, 2021 08:45 ET
|
Vericel Corporation
CAMBRIDGE, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that its...
Vericel to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021
June 09, 2021 09:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...
Vericel Announces Appointment of Lisa Wright to Board of Directors
June 02, 2021 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel to Present at the Canaccord Genuity Virtual Musculoskeletal Conference on Thursday, May 20, 2021
May 13, 2021 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...
Vericel Reports First Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance
May 05, 2021 07:00 ET
|
Vericel Corporation
First Quarter Total Net Revenue Increased 30% to $34.6 Million Full-Year 2021 Revenue Guidance Raised to $165-$168 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 05,...
Vericel to Report First-Quarter 2021 Financial Results on May 5, 2021
April 21, 2021 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel to Present at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021
April 09, 2021 09:24 ET
|
Vericel Corporation
CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...